Our products | Novo Nordisk U.S.
Novo Nordisk offers more than 20 medicines for diabetes, chronic weight management, rare bleeding disorders, hormone-related growth disorders and women’s health.
Diabetes Treatments | Novo Nordisk U.S.
View a list of Novo Nordisk's current diabetes products along with prescribing information and links to their individual product sites for patients and physicians.
Our products - Novo Nordisk
Overview of Novo Nordisk pharmaceutical products within diabetes, obesity, haemophilia, human growth hormone and hormone replacement therapy.
Explore Diabetes Products - Novo Nordisk
Explore how our diabetes treatments and digital health solutions can help improve the lives of people living with Type 1 and Type 2 diabetes.
Diabetes Treatments & Insulin Pen Devices | NovoCare®
Find information about Novo Nordisk medications and devices used to treat diabetes, including insulin and non-insulin medicines.
Our medicines | Diabetes medications | Obesity medication - Novo Nordisk
Overview of our diabetes medications, obesity medication and also medicines within haemophilia, human growth hormone and hormone replacement therapy.
About Diabetes | NovoCare® Diabetes Education
Novo Nordisk offers a broad range of options to treat diabetes as part of your diabetes care plan. We offer programs and services to help lower the cost of your diabetes medication or provide it free if you qualify, particularly for insulin. Find out whether your insurance covers your medication online in minutes.
Treatment Options for Type 2 Diabetes - NovoCare
There are many medication options for treating type 2 diabetes. Learn the differences between GLP-1 RA, insulin, non-insulin, oral anti-diabetic drugs, and more.
Novo Nordisk Product Library | Scientific Exchange
Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.
Type 1 diabetes - Novo Nordisk
From better treatments to digital solutions, we strive to ease the burden of living with a chronic disease and meet the diverse needs of millions of people living with type 1 diabetes. Within type 1 diabetes, we are currently researching into the following areas: Glucose-responsive insulins; Connected insulin delivery devices